CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-22 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −20,682 | $8.70 | $180K | 300,143 |
| 2026-02-22 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −40,650 | 40,651 | ||
| 2026-02-22 | Adcock Richard CEO & President | Option exercise | +152,439 | 637,904 | ||
| 2026-02-22 | Adcock Richard CEO & President | Shares withheld for taxes | −77,560 | $8.70 | $675K | 560,344 |
| 2026-02-22 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −152,439 | 152,439 | ||
| 2026-02-22 | Simon Barry J. Director | Option exercise 10b5-1 | +15,243 | 3,096,847 | ||
| 2026-02-22 | Simon Barry J. Director | Shares withheld for taxes 10b5-1 | −6,026 | $8.70 | $52K | 3,090,821 |
| 2026-02-22 | Simon Barry J. Director | Option exercise · Restricted Stock Units 10b5-1 | −15,243 | 15,245 | ||
| 2026-02-22 | LAUER REGAN J Chief Accounting Officer | Option exercise | +4,065 | 117,548 | ||
| 2026-02-22 | LAUER REGAN J Chief Accounting Officer | Shares withheld for taxes | −1,673 | $8.70 | $15K | 115,875 |
| 2026-02-22 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −4,065 | 4,065 | ||
| 2026-02-22 | SOON-SHIONG PATRICK See remarks | Option exercise | +114,329 | 29,816,081 | ||
| 2026-02-22 | SOON-SHIONG PATRICK See remarks | Shares withheld for taxes | −58,170 | $8.70 | $506K | 29,757,911 |
| 2026-02-22 | SOON-SHIONG PATRICK See remarks | Option exercise · Restricted Stock Units | −114,329 | 114,329 | ||
| 2026-02-20 | Simon Barry J. Director | Sale 10b5-1 | −10,000 | $9.25 | $93K | 3,081,604 |
| 2026-02-10 | Sachs David C. Chief Financial Officer | Option exercise | +82,236 | 322,818 | ||
| 2026-02-10 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −42,643 | $6.93 | $296K | 280,175 |
| 2026-02-10 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −82,236 | 164,474 | ||
| 2026-02-10 | Adcock Richard CEO & President | Option exercise | +274,122 | 625,513 | ||
| 2026-02-10 | Adcock Richard CEO & President | Shares withheld for taxes | −140,048 | $6.93 | $971K | 485,465 |
Page 3 of 12 · 226 trades